Pharma BD Deal Intelligence

Eisai Co. Ltd. / Ligand Pharmaceuticals (oncology product portfolio)

2006 · Asset Purchase · $205M · Complete

Acquired four oncology products: Ontak, Targretin (capsule and gel), Panretin

Key facts

• Announced Sep 15, 2006
• Deal value $205M
• Deal type Asset Purchase

← Browse all deals  ·  How we score deals